Board Meeting To Be Held On July 27, 2017
Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the meeting of the Board of Directors of the Company will be held on Thursday, July 27, 2017; inter-alia to consider unaudited financial results of the Company for first quarter ended June 30, 2017. Further, a copy of this notice will be made available on the website of the Company www.novartis.in. Updates
In continuation to our letter dated May 25, 2017 regarding Book Closure dates (from July 21, 2017 to July 28, 2017 both days inclusive) it may be noted that, the dividend if declared by the shareholders at the ensuing AGM on July 28, 2017, will be paid on and from August 2, 2017 to those shareholders whose name appears in the Register of Members as on July 20, 2017. Statement Of Investor Complaints For The Quarter Ended June 30, 2017
Statement of Investor Complaints/Grievances pursuant to Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 for the Quarter ended June 30, 2017 Publication Of Notice Of 69Th Annual General Meeting Of The Company To Be Held On July 28, 2017 In Newspapers.
Publication of Notice of 69th Annual General Meeting of the Company to be held on July 28, 2017 in newspapers. Updates
Clarification with respect to the query raised by BSE through their email dated May 31, 2017 Fixes Book Closure for Final Dividend & AGM
Novartis India Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from July 21, 2017 to July 28, 2017 (both days inclusive) for the purpose of Payment of Final Dividend & 69th Annual General Meeting (AGM) of the Company to be held on July 28, 2017. Board recommends Dividend
Novartis India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 23, 2017, inter alia, has recommended a dividend of Rs. 10 per share for the financial year ended March 31, 2017, subject to the approval of Shareholders at the ensuing Annual General Meeting. The Dividend, if approved by the Shareholders, will be paid within the prescribed statutory timelines. Board approves Dividend
The Board of Directors of Novartis India Limited at its meeting held today recommended a dividend of Rs. 10 per share for the financial year ended March 31, 2017, subject to the approval of Shareholders at the ensuing Annual General Meeting. The Dividend, if approved by the Shareholders, will be paid within the prescribed statutory timelines. Fixes Book Closure For Annual General Meeting
For the purpose of payment of final dividend upon being declared at the 69th AGM of the Company scheduled on July 28, 2017 Financial Results For The Quarter And Year Ended March 31, 2017
The Board of Directors of Novartis India Limited at its meeting held today has approved the Audited Financial Results for the quarter and financial year ended March 31, 2017. Please find enclosed herewith the Audited financial results for the quarter and financial year ended March 31, 2017 alongwith the Form A and Auditors Report as required under Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015....